Airway epithelial STAT3 inhibits allergic inflammation via upregulation of stearoyl-CoA desaturase 1-Reference-Cited by-同舟云学术

Airway epithelial STAT3 inhibits allergic inflammation via upregulation of stearoyl-CoA desaturase 1

Published:2022-10 Issue:4 Volume:71 Page:520-527
ISSN:1323-8930
Container-title:Allergology International
language:en
Short-container-title:Allergology International

Author:

Nishimura Nozomi,Yokota Masaya^ORCID,Kurihara Shunjiro,Iwata Arifumi,Kageyama Takahiro,Ito Takashi,Saku Aiko,Maezawa Yuko,Hirose Koichi,Nakajima Hiroshi

Funder

Takeda Science Foundation

Japan Science and Technology Agency

GlaxoSmithKline Japan

Japan Society for the Promotion of Science

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Elsevier BV

Subject

General Medicine,Immunology and Allergy

Reference36 articles.

1. Type 2 inflammation in asthma — present in most, absent in many;Fahy;Nat Rev Immunol,2015

2. Asthma;Papi;Lancet,2018

3. The airway epithelium in asthma;Lambrecht;Nat Med,2012

4. Barrier epithelial cells and the control of Type 2 immunity;Hammad;Immunity,2015

5. Signal transducer and activator of transcription 3: a year in review;Forbes;Curr Opin Hematol,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STATs, promising targets for the treatment of autoimmune and inflammatory diseases;European Journal of Medicinal Chemistry;2024-11

2. Metabolomic analysis of the effect of endocannabinoid metabolism inhibition in ovalbumin-induced allergic airway inflammation in Guinea pigs;2024-03-13

3. Lipid metabolism-related genes are involved in the occurrence of asthma and regulate the immune microenvironment;BMC Genomics;2024-02-01

4. SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors;Biomedicine & Pharmacotherapy;2024-01

5. Physiological and immunological barriers in the lung;Seminars in Immunopathology;2024-01